Describing the Quality Of Life in Colombian Patients mCRPC Under Treatment With RADium-223.
Latest Information Update: 30 Oct 2023
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- Acronyms QOLRAD
- Sponsors Bayer
- 25 Feb 2022 Planned End Date changed from 15 Feb 2023 to 15 Feb 2024.
- 25 Feb 2022 Planned primary completion date changed from 15 Feb 2023 to 15 Feb 2024.
- 07 Dec 2021 Planned End Date changed from 15 Jan 2023 to 15 Feb 2023.